These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2741752)

  • 1. Malignant hyperthermia in an office surgery suite: a case report.
    Turpin IM; Manino J
    Aesthetic Plast Surg; 1989; 13(2):121-3. PubMed ID: 2741752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
    Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H
    Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
    Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
    Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia].
    Houvenaeghel M; Achilli-Cornesse E; Jullian-Papouin H; Martin-Meyssonier A; Manelli JC
    Ann Fr Anesth Reanim; 1988; 7(5):408-11. PubMed ID: 3207229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much dantrolene? A case of fulminant malignant hyperthermia.
    Cain AG; Bell AD
    Anaesth Intensive Care; 1989 Nov; 17(4):500-2. PubMed ID: 2596684
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
    Inada H; Jinno S; Kohase H; Fukayama H; Umino M
    Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant hyperthermia in swine during isoflurane anesthesia].
    Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
    Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    Magistris F; Gamble J
    A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
    Litman RS; Joshi GP
    Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hyperthermia syndrome: A rare entity.
    García-Muro C; Sáenz-Moreno I; Riaño-Méndez B; Gutiérrez-Delgado JM; Valencia-Ramos J; Esteban-Zubero E
    Bol Med Hosp Infant Mex; 2020; 77(6):337-340. PubMed ID: 33186346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia. Considerations for the ophthalmologist.
    Sedwick LA; Romano PE
    Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.